Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Identifying cross-disease components of genetic risk across hospital data in the UK Biobank.

Cortes A. et al, (2019), Nat Genet

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.

du Pré MF. et al, (2019), The Journal of experimental medicine

A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Ooi JD. et al, (2019), Nat Commun, 10

Systematic classification of shared components of genetic risk for common human diseases

Cortes A. et al, (2018)

HLA variation and disease

Dendrou CA. et al, (2018), Nature Reviews Immunology, 18, 325 - 339

Immunomodulation in multiple sclerosis: promises and pitfalls

Dendrou CA. and Fugger L., (2017), Current Opinion in Immunology, 49, 37 - 43

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

Cortes A. et al, (2017), Nature Genetics, 49, 1311 - 1318

DOMINANT HLA-MEDIATED PROTECTION FROM THE RISK OF AUTOIMMUNE RENAL DISEASE IS CONFERRED BY ANTIGEN-SPECIFIC REGULATORY T CELLS

Ooi JD. et al, (2017), NEPHROLOGY, 22, 16 - 16

Structural and regulatory diversity shape HLA-C protein expression levels

Kaur G. et al, (2017), Nature Communications, 8

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells

Ooi JD. et al, (2017), Nature, 545, 243 - 247

IN ANTI-GBM DISEASE, HLA-PEPTIDE CONFORMATION DETERMINES SUSCEPTIBILITY OR PROTECTION FROM DISEASE

Ooi JD. et al, (2017), RHEUMATOLOGY, 56, 23 - 23

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

Cortes A. et al, (2017)

Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy

Haghikia A. et al, (2017), The Lancet Neurology, 16, 104 - 106

Neuroinflammation — using big data to inform clinical practice

Dendrou CA. et al, (2016), Nature Reviews Neurology, 12, 685 - 698

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

Dendrou CA. et al, (2016), Science Translational Medicine, 8, 363ra149 - 363ra149

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination

Grodeland G. et al, (2016), The Journal of Immunology, 197, 3575 - 3585

Amiloride does not protect retinal nerve fibre layer thickness following acute optic neuritis; result from a phase II, double blind, randomised controlled trial.

McKee JB. et al, (2016), MULTIPLE SCLEROSIS JOURNAL, 22, 21 - 22

Inhibitory Interplay between Orexin Neurons and Eating

González JA. et al, (2016), Current Biology, 26, 2486 - 2491

Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions

Jönsson P. et al, (2016), Proceedings of the National Academy of Sciences, 113, 5682 - 5687

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial

McKee JB. et al, (2015), BMJ Open, 5, e009200 - e009200

Load More

1
2
3
4
5

Include forthcoming?